Expression of CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) by blastic plasmacytoid dendritic cell neoplasms

JAMA Dermatology

Volumn 150, Issue 1, 2014, Pages 73-76

  Salva, Katrin A ^a   Haemel, Anna K ^b,c   Pincus, Laura B ^b,c   Liu, Jing ^d   Sundram, Uma ^e   Guitart, Joan ^f   Longley, B Jack ^a   Wood, Gary S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e STANFORD UNIVERSITY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD31 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN;

AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; BLOOD CLOTTING; CANCER CELL; CELL ADHESION; CELL INFILTRATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN CANCER; VERY ELDERLY;

AGED, 80 AND OVER; ANTIGENS, CD31; DENDRITIC CELLS; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; SKIN NEOPLASMS;

EID: 84892737955     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.7141     Document Type: Article

References (15)

1. Assaf C, Gellrich S, Whittaker S, et al. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol. 2007;60(9):981-989.
2. Kharfan-DabajaMA, Lazarus HM, Nishihori T, Mahfouz RA, Hamadani M. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013;19(7):1006-1012.
3. Yang CS,Wang J, Chang TK. Congenital blastic plasmacytoid dendritic cell neoplasm. Pediatr Blood Cancer. 2012;58(1):109-110.
4. PilichowskaME, Fleming MD, Pinkus JL, Pinkus GS. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. Am J Clin Pathol. 2007;128(3):445-453.
5. Cota C, Vale E, Viana I, et al. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol. 2010;34(1):75-87.
6. Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123(5):662-675.
7. Montes-Moreno S, Ramos-Medina R, Martínez-López A, et al. SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms. Blood. 2013;121(4):643-647.
8. Sale T,Wood GS, Longley BJ. Epstein-Barr virus-positive blastoid NK-cell lymphoma. In: Burg W, Kempf G, eds. Cutaneous Lymphomas: Unusual Cases. Vol 2. Darmstadt, Germany: Steinkopf; 2006: 2-55.
9. Salva K, Sundram U, Krathen M, et al. Analysis of protein expression in situ using multi-spectral imaging is superior to conventional immunohistochemistry (IHC): a new paradigm for patient selection for targeted therapy. J Invest Dermatol. 2013;133(S):169.
10. McKenney JK,Weiss SW, Folpe AL. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol. 2001;25(9):1167-1173.
11. Bergom C, Gao C, Newman PJ. Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival. Leuk Lymphoma. 2005;46(10):1409- 1421.
12. Nicholson SA, McDermott MB, DeYoung BR, Swanson PE. CD31 immunoreactivity in small round cell tumors. Appl Immunohistochem Mol Morphol. 2000;8(1):19-24.
13. Karpova MB, Fujii K, Jenni D, Dummer R, Urosevic-Maiwald M. Evaluation of lymphangiogenic markers in Sézary syndrome. Leuk Lymphoma. 2011;52(3):491-501.
14. Gao C, SunW, Christofidou-Solomidou M, et al. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood. 2003;102(1):169-179.
15. KishoreM,Ma L, Cornish G, Nourshargh S, Marelli-Berg FM. Primed T cell responses to chemokines are regulated by the immunoglobulin-like molecule CD31. PLoS One. 2012;7(6):e39433.